ADVERTISEMENT
Posted: Jul 15, 2021

Survey: One-third of consumers would ignore laws against buying from online pharmacies

According to a new survey from the Alliance for Safe Online Pharmacies (ASOP) Global Foundation, almost half of Americans gamble with their lives to buy medication from online sources—even though the overwhelming majority of them operate illegally. That’s just one of the alarming findings from the organization’s 2021 survey of American perceptions and use of online pharmacies, which was commissioned from Abacus Data.

Read more
Posted: Jul 13, 2021

FDA alerts health professionals about varenicline recall

After Pfizer announced in late June that it was halting worldwide distribution of varenicline (Chantix) after detecting elevated levels of nitrosamines in the drug, FDA came out to alert patients and health professionals about the voluntary recall.

Read more
Posted: Jul 12, 2021

Racial disparities in death rates from chronic conditions magnified in rural areas

Have we made any progress in improving racial health inequities since the early 2000s? Researchers at Harvard Medical School, who published their findings in the Journal of the American College of Cardiology, wanted to find out.

Read more
Posted: Jul 2, 2021

Liver injury from acetaminophen at low doses linked to fasting, heavy drinking

Acetaminophen is commonly used to treat minor aches and pains; however, patients have been cautioned about liver injury associated with overuse. Because of the extensive use of this medication, Louvet and colleagues at Hôpital Huriez and the Université de Lille (France) performed an evaluation of acute liver injury (ALI) associated with therapeutic doses (less than 6 g/d) of acetaminophen versus overdose levels.

Read more
Posted: Jul 2, 2021

Race, socioeconomic status associated with lower SGLT2 inhibitor use

If you are wondering what health care disparities might look like in medication use for chronic diseases, a new study published in JAMA Network Open can serve as just one example. Among patients with diabetes in the United States, researchers found that lower rates of SGLT2 inhibitor use, a medication with substantial cardioprotective and kidney protective benefits, is associated with Black race, Asian race, female gender, and lower household income.

Read more
First5556575860626364Last

Related Articles

Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT